Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Centralized imaging provides more accurate and consistent hair loss measurements in alopecia areata.

A new tool simplifies alopecia areata severity scoring but needs validation.

Photobiomodulation therapy effectively promotes hair regrowth and improves quality of life in alopecia areata without side effects.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Certain hair and scalp features can predict the severity of alopecia areata.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Compound glycyrrhizin combined with conventional treatments effectively and safely promotes hair regrowth in alopecia areata patients.

Compound glycyrrhizin with conventional treatments is effective and safe for promoting hair regrowth in alopecia areata.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Alopecia areata greatly affects quality of life, especially mental health, and newer assessment tools better capture this impact than older ones.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Phosphorus homeopathy treatment led to complete hair regrowth in two Alopecia Areata patients.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

The conclusion suggests that a new system for measuring hair loss could be created using automated analysis of photographs.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

People with alopecia areata often have low vitamin D levels, which may worsen their hair loss.

Mixing calcipotriol with a steroid is almost as effective as using a steroid alone for alopecia areata and has fewer side effects.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

AGA patients have a lower quality of life than AA patients.